1. CD44v6 acts as a directional responding factor in the process of transcoelomic metastasis from gastric carcinoma to Krukenberg tumor
   Ziqi Zhou et al, 2023, Expert Review of Molecular Diagnostics CrossRef
2. Identification of potential target genes of non-small cell lung cancer in response to resveratrol treatment by bioinformatics analysis
   Peng Gao et al, 2021, Aging CrossRef
3. SFPQ Promotes Lung Cancer Malignancy via Regulation of CD44 v6 Expression
   Libang Yang et al, 2022, Frontiers in Oncology CrossRef
4. Selection, characterization and in vivo evaluation of novel CD44v6-targeting antibodies for targeted molecular radiotherapy
   A. C. L. Mortensen et al, 2023, Scientific Reports CrossRef
5. CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies
   Iris Lodewijk et al, 2023, Frontiers in Immunology CrossRef
6. Nano Drug Delivery System for Tumor Immunotherapy: Next-Generation Therapeutics
   Lili Zhou et al, 2022, Frontiers in Oncology CrossRef